Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

Shionogi aims for digital transformation

Signs up with Accenture for seven-year work programme

- PMLiVE

The new basics

Innovative products and creative marketing  won’t help if our industry fails to address the new basics

- PMLiVE

Beverley Newbury becomes VCCP Health’s managing director

Her promotion follows nearly six years of service with the company

Storm Therapeutics bolsters its team

Professor Mark Dawson and Dr Paul Leeson join its scientific advisory board

- PMLiVE

MSD’s Keytruda wins bladder cancer indication in Japan

Becomes first anti-PD1 approved in the country for previously treated UC

- PMLiVE

FDA’s year-end approvals take annual tally to 46

Rhopressa and Steglatro were among the final medicines licensed last year

- PMLiVE

Mallinckrodt pays $1.2bn for Sucampo Pharma

The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects

- PMLiVE

Delivering real patient value

Three practical steps to achieving a patient-focused comms plan

- PMLiVE

Taming the Monster

Will pharma’s pursuit of marketing effectiveness continue to give it sleepless nights?

- PMLiVE

Astellas promotes Anthony Fiordaliso to VP, Americas finance

He first joined the pharma firm in 2010 from Schering-Plough

Are you providing the kind of content that affiliates want? 5 questions to answer.

To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning core materials.

Anthill Agency

Roche Basel Switzerland

Roche buys cancer company Ignyta for $1.7bn

Pursues same oncology target that encouraged Bayer's recent deal with Loxo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links